We isolated neutrophils from bronchiectasis patients and treated them with MCC950 (an NLRP3 inhibitor, 10 μM) or Z-VAD-FMK (a caspase inhibitor, 20 μM), followed by stimulation with LPS and nigericin. This evidence concerns the gene NLRP3 and bronchiectasis.